Mammaprint and blueprint as prognostic indicators for elderly patients with early stage breast cancer

被引：0
|
作者：
Blumencranz, Peter W. [1 ]
Habibi, Mehran [2 ]
Blumencranz, Lisa [3 ]
Menicucci, Andrea [3 ]
Wang, Shiyu [3 ]
Truitt, Amy [3 ]
Audeh, William [3 ]
Baginski, Jolanta L. [1 ]
Shivers, Steven [4 ]
Acs, Geza [5 ,6 ]
Cox, Charles E. [4 ]
机构：
[1] Morton Plant Hosp, Clearwater, FL USA
[2] Johns Hopkins Breast Ctr Bayview, Baltimore, MD USA
[3] Agendia Inc, Med Affairs, Irvine, CA USA
[4] Univ S Florida, Tampa, FL 33620 USA
[5] AdventHlth Tampa, Tampa, FL USA
[6] Ruffolo Hooper & Associates, Tampa, FL USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS6-41
引用
收藏
页数：2
相关论文
共 50 条
  • [1] MammaPrint and BluePrint as Prognostic Indicators for Elderly Patients with Early-stage Breast Cancer
    Blumencranz, Peter
    Habibi, Mehran
    Blumencranz, Lisa
    Menicucci, Andrea
    Audeh, William
    Yoder, Erin
    Shivers, Steve
    Acs, Geza
    Cox, Charles
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S293 - S294
  • [2] MammaPrint and BluePrint comprehensively capture the cancer hallmarks in early-stage breast cancer patients
    Haan, Josien C.
    Bhaskaran, Rajith
    Ellappalayam, Architha
    Bijl, Yannick
    Griffioen, Christian J.
    Lujinovic, Ersan
    Audeh, William M.
    Penault-Llorca, Frederique
    Mittempergher, Lorenza
    Glas, Annuska M.
    GENES CHROMOSOMES & CANCER, 2022, 61 (03): : 148 - 160
  • [3] MammaPrint and BluePrint in early breast cancer: Clinical implications of prognostic stratification and molecular subtyping
    Yao, K.
    Turk, M.
    Kaul, K.
    Wesseling, J.
    Stork-Sloots, L.
    de Snoo, F.
    Cristofanilli, M.
    CANCER RESEARCH, 2013, 73
  • [4] MammaPrint and BluePrint Next-Generation Sequencing (NGS) Results Are Robust and Accurate for Patients with Early Stage Breast Cancer
    Kingma, D.
    Uygun, S.
    Zanette, C.
    Mee, S.
    Witteveen, A.
    Delahaye, L.
    Mittempergher, L.
    Chan, B.
    Glas, A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (11): : S63 - S63
  • [5] Identification of transcriptional changes with MammaPrint and BluePrint in early-stage breast cancer after neoadjuvant chemotherapy.
    Chung, Alice P.
    Srour, Marissa K.
    Dadmanesh, Farnaz
    Kim, Sungjin
    Giuliano, Armando E.
    Wei, Jennifer
    Huynh, Yen
    Haan, Josien
    Wang, Shiyu
    Menicucci, Andrea
    Dauer, Patricia
    Audeh, M. William
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] MammaPrint and BluePrint identify racial disparities among women with HR+HER2-early-stage breast cancer
    Reid, Sonya
    Shu, Xiao-Ou
    Venton, Lindsay
    Haan, Josien
    Menicucci, Andrea
    Dauer, Patricia
    Audeh, William
    Pal, Tuya
    CANCER RESEARCH, 2024, 84 (09)
  • [7] Different MammaPrint and BluePrint molecular profiles and clinical-pathological features of early stage breast cancer in Chinese patients in the United States and Hong Kong
    Kwong, Ava
    Untch, Sarah
    Kling, Heather M.
    Finn, Christine
    Audeh, William
    Shin, Vivian
    Ishtihar, Sherene
    Chen, Margaret
    CANCER RESEARCH, 2020, 80 (04)
  • [8] Impact of MammaPrint and BluePrint on early breast cancer treatment decisions: WSG PRIMe study results
    Wurstlein, R.
    Gluz, O.
    Grischke, E. M.
    Kates, R. E.
    Thill, M.
    Hasmueller, S.
    Knauer, M.
    Pusch, R.
    Harbeck, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 6 - 6
  • [9] PROGNOSTIC INDICATORS IN NODE-NEGATIVE EARLY STAGE BREAST-CANCER
    WONG, WW
    VIJAYAKUMAR, S
    WEICHSELBAUM, RR
    AMERICAN JOURNAL OF MEDICINE, 1992, 92 (05): : 539 - 548
  • [10] Impact of MammaPrint and BluePrint on early breast cancer treatment decisions: WSG PRIMe study results
    Wuerstlein, R.
    Grischke, E. M.
    Gluz, O.
    Kates, R.
    Persoon, M.
    Thill, M.
    Hasmueller, S.
    Knauer, M.
    Pusch, R.
    Harbeck, N.
    BREAST, 2017, 32 : S107 - S107
12345